C19 Treatments

Does the Commonwealth have the power to recommend ‘vaccinations’ and booster shots?

The Constitution provides the subject matters of which the Commonwealth has its law making powers, within those powers are limited health powers. Section 51(xxiiiA) is known as the funding power of the Commonwealth, which is a power to fund medical and dental services, pharmaceutical benefits and alike. The States hold the power to regulate health, …

Does the Commonwealth have the power to recommend ‘vaccinations’ and booster shots? Read More »

Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To Horse Paste

by Tyler Durden Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that it’s launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease. Coincidentally (or not), Pfizer’s drug shares at least one mechanism of action …

Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To Horse Paste Read More »

Whats up with Ivermectin?

Could a drug discovered in the 1970s help tackle the Covid-19 pandemic?Why won’t they listen?Despite VERY promising results,  governments and the medical machine is purposely turning a blind eye.View this drug’s live study data here In this video Bret Weinstein and Heather Heying (both PhDs in Biology) discuss ivermectin. REFERENCES: FDA’s Emergency Use Authorization Guidelines: …

Whats up with Ivermectin? Read More »

Proxalutamide reduces COVID-19 mortality risk by 92 percent

In a Phase III trial, Proxalutamide reduced mortality and expedited recovery of hospitalised COVID-19 patients in Brazil. In a clinical trial, Proxalutamide reduced COVID-19 mortality risk by 92 percent and shortened the median hospital stay of patients by nine days. The investigator-initiated trial (NCT04728802), conducted by Dr Andy Goren and Dr Flávio Adsuara Cadegiani at 12 sites …

Proxalutamide reduces COVID-19 mortality risk by 92 percent Read More »

Masterclass on SARS-CoV-2

Evidence shows that this virus is engineered with Gain of Function (GoF) including mechanisms creating anInflammo Thrombotic Response (ITR) with mRNA Reverse Transcription (RT) into cell DNA with Prion-like structurespresent in the virus spike protein. Additional information Reports Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry Receptor usage …

Masterclass on SARS-CoV-2 Read More »

Proxalutamide reduces COVID-19 mortality risk by 92 percent

By Hannah Balfour (European Pharmaceutical Review) In a Phase III trial, Proxalutamide reduced mortality and expedited recovery of hospitalised COVID-19 patients in Brazil. In a clinical trial, Proxalutamide reduced COVID-19 mortality risk by 92 percent and shortened the median hospital stay of patients by nine days. The investigator-initiated trial (NCT04728802), conducted by Dr Andy Goren and Dr …

Proxalutamide reduces COVID-19 mortality risk by 92 percent Read More »

Vitamin D (calcifediol) can ‘reduce Covid deaths by up to 60%

Research, published by the Social Science Research Network, found Covid-19 patients given doses of Vitamin D were 80 per cent less likely to require ICU treatment.  Those from the University of Barcelona also concluded that ‘adjusted results showed a reduced mortality of more than 60 per cent’ for those who were given the calcifediol treatment.  The …

Vitamin D (calcifediol) can ‘reduce Covid deaths by up to 60% Read More »

Scroll to Top